6 September 2016 - - Spanish healthcare company Grifols (MCE: GRF) (NASDAQ: GRFS) has opened a new training centre in Dubai, the company said on Tuesday.

Created to support the company's growing Diagnostic business, the centre will offer single and multi-day training courses for laboratory technicians, engineers, and specialists working with the company's portfolio of transfusion medicine and clinical diagnostic instruments, assays, and software.

The centre will also train attendees on associated best practices in the laboratory.

Grifols said it is paving the way for the growth of its diagnostic division through the introduction of new products, entry into new markets, and strengthening of its presence in areas where it already operates.

The division is focused on advancing patient care with innovative diagnostic solutions designed to simplify laboratory operations and improve the detection and management of disease.

Grifols is in the development of protein therapies, hospital pharmacy products, and diagnostic technology for clinical use.

The company is present in more than 100 countries worldwide and its headquarters are located in Barcelona, Spain.

Grifols is in plasma collection with a network of 160 plasma donation centres in the US, and is a producer of plasma-derived medicines.

The company offers a range of transfusion medicine, hemostasis, and immunoassay solutions for clinical laboratories, blood banks, and transfusion centres.

In 2015, sales exceeded EUR 3.934bn with a headcount close to 14,700 employees. Grifols demonstrates its commitment to advancing healthcare by allocating a significant portion of its annual income to Rand D.